Dr. Jose Lutzky, MD
Claim this profileUniversity of Miami
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
41 drugs studied
About Jose Lutzky, MD
Education:
- Earned a Medical Degree (MD) from Universidade Federal do Rio Grande do Sul, Brazil, in 1980.
Experience:
- Completed an Internship and Residency in Internal Medicine, with a Residency at Mount Sinai Medical Center, Miami Beach, Florida.
- Undertook a Fellowship in Hematology/Oncology at Columbia University's New York-Presbyterian Hospital.
- Triple board-certified in hematology, oncology, and internal medicine, with over 40 years of experience.
- Serves as the Director of Cutaneous Oncology Services and Clinical Trials Coordinating Unit at Sylvester Comprehensive Cancer Center.
- Holds a Professorship in the Department of Medicine at the University of Miami.
Area of expertise
1Melanoma
Global LeaderStage IV
BRAF positive
Stage III
2Skin Cancer
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Jose Lutzky, MD is currently running
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting1 award Phase 1 & 2
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
More about Jose Lutzky, MD
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jose Lutzky, MD has experience with
- Nivolumab
- Ipilimumab
- Cemiplimab
- RP1
- Relatlimab
- DF6002
Breakdown of trials Jose Lutzky, MD has run
Melanoma
Skin Cancer
Eye Cancer
Uveal Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jose Lutzky, MD specialize in?
Jose Lutzky, MD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Jose Lutzky, MD currently recruiting for clinical trials?
Yes, Jose Lutzky, MD is currently recruiting for 6 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Jose Lutzky, MD has studied deeply?
Yes, Jose Lutzky, MD has studied treatments such as Nivolumab, Ipilimumab, Cemiplimab.
What is the best way to schedule an appointment with Jose Lutzky, MD?
Apply for one of the trials that Jose Lutzky, MD is conducting.
What is the office address of Jose Lutzky, MD?
The office of Jose Lutzky, MD is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.